Real-World Comparative Effectiveness of Nab-paclitaxel and Standard of Care Chemotherapies in Patients With Platinum-Resistant Ovarian Cancer (COMPASS 2.0)

Presented: European Society for Medical Oncology Gynaecological Cancers Annual Congress, 18 June 2026, CopenhagenDK

Presenter: Mark S. ShahinMD, FACOG, FACS


Scientific journal publications or scientific congress presentations may include information regarding investigational products or uses.

Download Poster

© 2026 Corcept Therapeutics, Incorporated

Privacy Notice | Terms of Use | Site Map | Your Privacy Choices | LinkedIn | Youtube

Privacy Notice

Terms of Use

Site Map

Your Privacy Choices

LinkedIn

Youtube